These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2215118)

  • 1. [The clinical quality evaluation of radiopharmaceutical preparations for diagnostic use].
    Korsunskiĭ VN; Tarasenko IuI; Tuktaev AV
    Med Radiol (Mosk); 1990 Sep; 35(9):60-3. PubMed ID: 2215118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the quality of radiopharmaceutics].
    Korsunskiĭ VN; Tarasov NF; Kodina GE; Malinin AB
    Med Radiol (Mosk); 1991; 36(4):27-33. PubMed ID: 2034083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the quality of a diagnostic radiopharmaceutical preparation].
    Levin VI
    Med Radiol (Mosk); 1980 Feb; 25(2):26-31. PubMed ID: 7360013
    [No Abstract]   [Full Text] [Related]  

  • 4. [Internal irradiation doses in patients during the diagnostic use of colloidal radiopharmaceutics].
    Popov VI; Korsunskiĭ VN; Tarasenko IuI; Bogdanovich AI
    Med Radiol (Mosk); 1989 Mar; 34(3):35-8. PubMed ID: 2927275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biokinetic and dosimetric modelling in the estimation of radiation risks from internal emitters.
    Harrison J
    J Radiol Prot; 2009 Jun; 29(2A):A81-A105. PubMed ID: 19454809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow dosimetry using blood-based models for radiolabeled antibody therapy: a multiinstitutional comparison.
    Wessels BW; Bolch WE; Bouchet LG; Breitz HB; Denardo GL; Meredith RF; Stabin MG; Sgouros G;
    J Nucl Med; 2004 Oct; 45(10):1725-33. PubMed ID: 15471841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality control of radiopharmaceutical kits.
    Billinghurst MW
    J Nucl Med; 1973 Jun; 14(6):362-4. PubMed ID: 4701837
    [No Abstract]   [Full Text] [Related]  

  • 12. Uterine artery embolization as a treatment option for uterine myomas.
    Marshburn PB; Matthews ML; Hurst BS
    Obstet Gynecol Clin North Am; 2006 Mar; 33(1):125-44. PubMed ID: 16504811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates.
    Siegel JA; Thomas SR; Stubbs JB; Stabin MG; Hays MT; Koral KF; Robertson JS; Howell RW; Wessels BW; Fisher DR; Weber DA; Brill AB
    J Nucl Med; 1999 Feb; 40(2):37S-61S. PubMed ID: 10025848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human biodistribution and dosimetry of the PET perfusion agent copper-62-PTSM.
    Wallhaus TR; Lacy J; Whang J; Green MA; Nickles RJ; Stone CK
    J Nucl Med; 1998 Nov; 39(11):1958-64. PubMed ID: 9829589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials of cost effectiveness in technology evaluation.
    Valk PE
    Q J Nucl Med; 2000 Jun; 44(2):197-203. PubMed ID: 10967629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiopharmaceuticals. Radiopharmaceuticals Drafting Group.
    Pharmacol Toxicol; 1991 Mar; 68(3):228-32. PubMed ID: 2057455
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck.
    Colnot DR; Quak JJ; Roos JC; van Lingen A; Wilhelm AJ; van Kamp GJ; Huijgens PC; Snow GB; van Dongen GA
    J Nucl Med; 2000 Dec; 41(12):1999-2010. PubMed ID: 11138685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapy.
    Breitz HB; Wendt RE; Stabin MS; Shen S; Erwin WD; Rajendran JG; Eary JF; Durack L; Delpassand E; Martin W; Meredith RF
    J Nucl Med; 2006 Mar; 47(3):534-42. PubMed ID: 16513624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radionuclide calibrator comparisons and quality improvement in nuclear medicine.
    Oropesa P; Woods MJ; Olsovcová V; dos Santos JA
    Appl Radiat Isot; 2008 Mar; 66(3):353-61. PubMed ID: 17855099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.